View updates on the COVE study & learn how your participation could help find a vaccine for COVID-19
Learn More
In using mRNA to develop medicines, we take advantage of normal biological processes to create a desired therapeutic effect. This give us the potential to treat a broad spectrum of diseases, many of which cannot be addressed with current therapies.
Read more about our mRNA Platform
Our Research Engine combines proprietary digital drug design tools and a highly automated production facility to enable Moderna and our partners to accelerate the pace of research, from idea development to development candidate nomination.
Learn More
Our Norwood, MA manufacturing facility allows us to produce the materials needed to supply our pre-clinical and Phase 1 and Phase 2 clinical development programs and the infrastructure required to anticipate future program demand.
Learn More
Moderna's CSR efforts are focused on the development of mRNA medicines - including potential medicines for public health needs - as well as on our employees, the environment, our communities and strong corporate governance.
Read More >